echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Professor Hu Bing's team from West China Hospital of Sichuan University published an article in Endoscopy revealing that it used a self-developed artificial intelligence-assisted diagnosis system to find the smallest area of early esophageal cancer

    Professor Hu Bing's team from West China Hospital of Sichuan University published an article in Endoscopy revealing that it used a self-developed artificial intelligence-assisted diagnosis system to find the smallest area of early esophageal cancer

    • Last Update: 2022-11-26
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
      

    Recently, Professor Hu Bing's team of the Department of Gastroenterology of our hospital published a research article Artificial intelligence for detecting and delineating a small flat-type early esophageal squamous cell carcinoma under multimodal in Endoscopy (IF:10.
    437), a well-known journal in the field of endoscopy Imaging, revealing the whole process
    of the team using the self-developed artificial intelligence-assisted diagnosis system to find a case of early esophageal cancer with the smallest area reported in the international literature and successfully implement endoscopic minimally invasive treatment.
    Professor Hu Bing is the corresponding author, and Dr.
    Yuan Xianglei is the first author
    .

    This paper objectively and comprehensively describes the real-time assisted detection and accurate delineation of this flat early esophageal cancer with an area of only 3mmx2.
    6mm in four endoscopic modes (white light endoscopy, iodine staining, non-magnified and magnified narrowband spectral imaging
    ).
    After the early esophageal cancer was found, the patient immediately received endoscopic minimally invasive treatment, and the postoperative pathological examination results confirmed that the tumor invaded the mucosal lamina propria, which belonged to the T1A stage and had a good
    prognosis.
    For such a small early esophageal cancer lesion, as long as the doctor is not careful or moves a little faster, it is easy to miss the diagnosis
    .

    In recent years, artificial intelligence (AI) assisted diagnosis technology has developed rapidly and made great progress
    in early esophageal cancer.
    However, most AI-assisted diagnostic products for early esophageal cancer can only roughly mark the suspicious lesion site in the form of a rectangular box, and cannot accurately outline the lesion boundary
    in the image.
    Professor Hu Bing's team focused on the pain points and difficulties of similar products and developed this AI-assisted diagnosis product
    that can perform real-time auxiliary detection in multiple endoscopic modes and outline the boundary of early esophageal cancer.
    This AI-assisted diagnosis system is not only the world's first artificial intelligence system that combines multiple endoscopic modes for the detection of early esophageal cancer, but also the world's first artificial intelligence system
    that can accurately delineate the boundary of early esophageal cancer under white light endoscopy.

    The early esophageal cancer AI-assisted diagnosis product developed by Professor Hu Bing's team is suitable for the mainstream digestive endoscopy instruments currently used in most hospitals, and can be "embedded" in endoscopic displays, which is convenient to use on a single screen, without changing the operating habits of endoscopists, and has high clinical practicability
    .
    The product has obtained the Class II medical device certificate and was shortlisted for the 2022 Ministry of Industry and Information Technology Artificial Intelligence Medical Device Innovation Task Unveiling
    .

    The successful development and clinical application of AI-assisted diagnosis products for early esophageal cancer is not only conducive to improving the detection rate of early esophageal cancer in grassroots hospitals in China, realizing early detection, early diagnosis and early screening, and improving the prognosis of esophageal cancer patients, but also has great significance
    for promoting technological innovation and transformation in key areas of esophageal cancer diagnosis.


    Original link:


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.